Late Night Salivary Cortisol in the Diagnosis of Neoplastic Hypercortisolism (including Cyclic Cushing's Syndrome)
Overview
Authors
Affiliations
Late night salivary cortisol (LNSC) is a mainstay in the diagnosis of neoplastic hypercortisolism (Cushing's syndrome) with a sensitivity and specificity of > 90% in patients with syndromic signs and symptoms. Intermittent hormonogenesis (day to day variation) is common in milder Cushing's disease whereas true cyclic Cushing's syndrome (weeks to months of tumor quiescence) is unusual. In both cases, LNSC is useful as a sensitive evaluative diagnostic tool, although its lower specificity may lead to false positive results in patients without Cushing's disease. Furthermore, intermittent hormonogenesis may lead to false negative LNSC results in patients with mild Cushing's disease. Finally, LNSC is useful as an approach to follow patients after pituitary surgery to detect a recurrence even many years after a full remission.
Who and how to screen for endogenous hypercortisolism in patients with mood disorders.
Ferrante E, Simeoli C, Mantovani G, Pivonello R J Endocrinol Invest. 2024; .
PMID: 39531206 DOI: 10.1007/s40618-024-02457-5.
Emerging diagnostic methods and imaging modalities in cushing's syndrome.
Wright K, van Rossum E, Zan E, Werner N, Harris A, Feelders R Front Endocrinol (Lausanne). 2023; 14:1230447.
PMID: 37560300 PMC: 10407789. DOI: 10.3389/fendo.2023.1230447.
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome.
Findling J, Raff H J Endocr Soc. 2023; 7(8):bvad087.
PMID: 37440963 PMC: 10334485. DOI: 10.1210/jendso/bvad087.
Cortisol Immunosensors: A Literature Review.
Karachaliou C, Koukouvinos G, Goustouridis D, Raptis I, Kakabakos S, Petrou P Biosensors (Basel). 2023; 13(2).
PMID: 36832050 PMC: 9954523. DOI: 10.3390/bios13020285.
Special issue: Cushing's disease update.
Fleseriu M Pituitary. 2022; 25(5):687-688.
PMID: 36001219 DOI: 10.1007/s11102-022-01271-7.